HWP
INSM icon

Highline Wealth Partners’s Insmed INSM Stock Holding History

Highline Wealth Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.07K Hold
10
– – ﹤0.01% 1266
2026
Q1 		$1.64K Buy
10
+8
+400% +$1.23K ﹤0.01% 1086
2025
Q4 		$348 Buy
+2
New +$365 ﹤0.01% 1018
2025
Q2 		– Sell
-48
Closed -$3.66K – 983
2025
Q1 		$3.66K Buy
+48
New +$3.67K ﹤0.01% 503

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Highline Wealth Partners's INSM Position: Q2 2026 in Review

Highline Wealth Partners held its Insmed (INSM) position steady in Q2 2026 at 10 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1266.

Highline Wealth Partners first reported a position in INSM in Q1 2025 and has held it in 4 quarters since. The position peaked at $3.66K in Q1 2025. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Highline Wealth Partners held 10 shares of Insmed worth $1.07K as of Q2 2026.
  • Highline Wealth Partners left its Insmed share count unchanged in Q2 2026.
  • Insmed made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #1266 holding.
  • Highline Wealth Partners first reported a position in Insmed in Q1 2025 and has held it in 4 quarters since.
  • Highline Wealth Partners's Insmed position peaked at $3.66K in Q1 2025.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.